Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:21364152rdf:typepubmed:Citationlld:pubmed
pubmed-article:21364152lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:21364152lifeskim:mentionsumls-concept:C0008976lld:lifeskim
pubmed-article:21364152lifeskim:mentionsumls-concept:C0155626lld:lifeskim
pubmed-article:21364152lifeskim:mentionsumls-concept:C1274040lld:lifeskim
pubmed-article:21364152lifeskim:mentionsumls-concept:C0038257lld:lifeskim
pubmed-article:21364152lifeskim:mentionsumls-concept:C1707455lld:lifeskim
pubmed-article:21364152lifeskim:mentionsumls-concept:C0581603lld:lifeskim
pubmed-article:21364152lifeskim:mentionsumls-concept:C2825200lld:lifeskim
pubmed-article:21364152pubmed:issue2lld:pubmed
pubmed-article:21364152pubmed:dateCreated2011-4-20lld:pubmed
pubmed-article:21364152pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21364152pubmed:abstractTextIn the prospective, randomized Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) trial, implantation of paclitaxel-eluting stents (PES) safely reduced the rates of ischemic target lesion revascularization (TLR) compared with bare metal stents (BMS) in patients with ST-segment-elevation myocardial infarction (STEMI) undergoing primary percutaneous intervention. Diabetes mellitus is a known predictor of adverse outcomes after percutaneous intervention in STEMI. We therefore sought to assess the impact of PES in diabetic patients with STEMI from the HORIZONS-AMI trial.lld:pubmed
pubmed-article:21364152pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21364152pubmed:languageenglld:pubmed
pubmed-article:21364152pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21364152pubmed:citationSubsetIMlld:pubmed
pubmed-article:21364152pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21364152pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21364152pubmed:statusMEDLINElld:pubmed
pubmed-article:21364152pubmed:monthAprlld:pubmed
pubmed-article:21364152pubmed:issn1941-7632lld:pubmed
pubmed-article:21364152pubmed:authorpubmed-author:NikolskyEugen...lld:pubmed
pubmed-article:21364152pubmed:authorpubmed-author:MehranRoxanaRlld:pubmed
pubmed-article:21364152pubmed:authorpubmed-author:StoneGregg...lld:pubmed
pubmed-article:21364152pubmed:authorpubmed-author:LanskyAlexand...lld:pubmed
pubmed-article:21364152pubmed:authorpubmed-author:PerugaJan ZJZlld:pubmed
pubmed-article:21364152pubmed:authorpubmed-author:GuagliumiGiul...lld:pubmed
pubmed-article:21364152pubmed:authorpubmed-author:BrodieBruce...lld:pubmed
pubmed-article:21364152pubmed:authorpubmed-author:KornowskiRanRlld:pubmed
pubmed-article:21364152pubmed:authorpubmed-author:DudekDariuszDlld:pubmed
pubmed-article:21364152pubmed:authorpubmed-author:PariseHelenHlld:pubmed
pubmed-article:21364152pubmed:authorpubmed-author:HartmannFranz...lld:pubmed
pubmed-article:21364152pubmed:authorpubmed-author:HoodKristin...lld:pubmed
pubmed-article:21364152pubmed:authorpubmed-author:WöhrleJochenJlld:pubmed
pubmed-article:21364152pubmed:authorpubmed-author:Witzenbichler...lld:pubmed
pubmed-article:21364152pubmed:copyrightInfo© 2011 American Heart Association, Inc.lld:pubmed
pubmed-article:21364152pubmed:issnTypeElectroniclld:pubmed
pubmed-article:21364152pubmed:day1lld:pubmed
pubmed-article:21364152pubmed:volume4lld:pubmed
pubmed-article:21364152pubmed:ownerNLMlld:pubmed
pubmed-article:21364152pubmed:authorsCompleteYlld:pubmed
pubmed-article:21364152pubmed:pagination130-8lld:pubmed
pubmed-article:21364152pubmed:meshHeadingpubmed-meshheading:21364152...lld:pubmed
pubmed-article:21364152pubmed:meshHeadingpubmed-meshheading:21364152...lld:pubmed
pubmed-article:21364152pubmed:meshHeadingpubmed-meshheading:21364152...lld:pubmed
pubmed-article:21364152pubmed:meshHeadingpubmed-meshheading:21364152...lld:pubmed
pubmed-article:21364152pubmed:meshHeadingpubmed-meshheading:21364152...lld:pubmed
pubmed-article:21364152pubmed:meshHeadingpubmed-meshheading:21364152...lld:pubmed
pubmed-article:21364152pubmed:meshHeadingpubmed-meshheading:21364152...lld:pubmed
pubmed-article:21364152pubmed:meshHeadingpubmed-meshheading:21364152...lld:pubmed
pubmed-article:21364152pubmed:meshHeadingpubmed-meshheading:21364152...lld:pubmed
pubmed-article:21364152pubmed:meshHeadingpubmed-meshheading:21364152...lld:pubmed
pubmed-article:21364152pubmed:meshHeadingpubmed-meshheading:21364152...lld:pubmed
pubmed-article:21364152pubmed:meshHeadingpubmed-meshheading:21364152...lld:pubmed
pubmed-article:21364152pubmed:meshHeadingpubmed-meshheading:21364152...lld:pubmed
pubmed-article:21364152pubmed:meshHeadingpubmed-meshheading:21364152...lld:pubmed
pubmed-article:21364152pubmed:year2011lld:pubmed
pubmed-article:21364152pubmed:articleTitlePaclitaxel-eluting stents compared with bare metal stents in diabetic patients with acute myocardial infarction: the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) trial.lld:pubmed
pubmed-article:21364152pubmed:affiliationCharité Campus Benjamin Franklin, Berlin, Germany.lld:pubmed
pubmed-article:21364152pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:21364152pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:21364152pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:21364152pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:21364152lld:pubmed